Association of rivaroxaban and apixaban therapy with major ischemic or bleeding events in patients with atrial fibrillation. Retrospective cohort real-world evidence study. Press release
https://doi.org/10.15829/1560-4071-2022-4906
References
1. Ray WA, Chung CP, Stein CM, et al. Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation. JAMA. 2021;326(23):2395-404. doi:10.1001/jama.2021.21222.
2. Brief instructions for the medical use of the drug Eliquis® Reg. unit No.: LP-002007, L P-001475. (In Russ.)
Review
For citations:
Association of rivaroxaban and apixaban therapy with major ischemic or bleeding events in patients with atrial fibrillation. Retrospective cohort real-world evidence study. Press release. Russian Journal of Cardiology. 2022;27(1S):4906. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4906
Views:
3270
Email this article 